Spark Therapeutics, Inc. - FORM 10-K - XML - IDEA: XBRL DOCUMENT - March 14, 2016

Attached files

file filename
EX-23.1 - EXHIBIT 23.1 - Spark Therapeutics, Inc.exhibit231-kpmgconsent.htm
EX-32.2 - EXHIBIT 32.2 - Spark Therapeutics, Inc.spark20151231ex-322.htm
EX-32.1 - EXHIBIT 32.1 - Spark Therapeutics, Inc.spark-20151231exx321.htm
EX-31.2 - EXHIBIT 31.2 - Spark Therapeutics, Inc.spark-20151231exx312.htm
EX-10.33 - EXHIBIT 10.33 - Spark Therapeutics, Inc.spark-20151231ex1033xuirfl.htm
EX-10.35 - EXHIBIT 10.35 - Spark Therapeutics, Inc.spark20151231-ex10353711le.htm
EX-10.36 - EXHIBIT 10.36 - Spark Therapeutics, Inc.spark-20151231xex1036chopp.htm
EX-10.31 - EXHIBIT 10.31 - Spark Therapeutics, Inc.spark-20151231ex1031univer.htm
EX-10.32 - EXHIBIT 10.32 - Spark Therapeutics, Inc.spark-20151231xex1032jmarr.htm
EX-10.34 - EXHIBIT 10.34 - Spark Therapeutics, Inc.spark-20151231xex1034chopm.htm
10-K - 10-K - Spark Therapeutics, Inc.spark-201510xk.htm
EX-31.1 - EXHIBIT 31.1 - Spark Therapeutics, Inc.spark-20151231exx311.htm
v3.3.1.900
Label Element Value
Limited Liability Company (LLC) Members' Equity, Unit-based Compensation us-gaap_LimitedLiabilityCompanyLLCMembersEquityUnitBasedCompensation $ 646,585
Stock Issued During Period, Value, New Issues us-gaap_StockIssuedDuringPeriodValueNewIssues 10,000,000
Member Units [Member]  
Limited Liability Company (LLC) Members' Equity, Unit-based Compensation us-gaap_LimitedLiabilityCompanyLLCMembersEquityUnitBasedCompensation 646,585
Stock Issued During Period, Value, Purchase of Assets us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets $ 50,000,000
Stock Issued During Period, Shares, Purchase of Assets us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets 25,000,000
Stock Issued During Period, Shares, New Issues us-gaap_StockIssuedDuringPeriodSharesNewIssues 5,870,000
Retained Earnings [Member]  
Net Income (Loss) Attributable to Parent us-gaap_NetIncomeLoss $ (57,277,797)
Series A Preferred Stock [Member] | Member Units [Member]  
Stock Issued During Period, Value, New Issues us-gaap_StockIssuedDuringPeriodValueNewIssues $ 10,000,000
Stock Issued During Period, Shares, New Issues us-gaap_StockIssuedDuringPeriodSharesNewIssues 5,000,000

Spark Therapeutics, Inc. Reports